A recent report published by Infinium Global Research on the cyberknife market provides an in-depth analysis of segments and sub-segments in the global as well as regional cyberknife market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional cyberknife market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global cyberknife market. According to the report, the global cyberknife market is projected to grow at a CAGR of 9.2% over the forecast period of 2019-2025.

Market Insight

Cyberknife is a stereotactic radiosurgery system used in the treatment of benign cancers, malignant cancers without affecting healthy cells. Nowadays it is also used in the treatment of the cancer of the pancreas, liver, lung, prostate, spine, and cancer of the throat. For lung cancer, it uses Synchrony software during radiotherapy well as it can function properly even the patient is breathing. As it uses the surgical placed internal fiducials and light-emitting optical fibers with combination, mounted on the patient body where the optical fibers are tracked by infrared tracking camera. Therefore, it is called the synchrony system or synchrony method. It takes 1 to 5 days to complete the treatment while each treatment session lasts between 30 to 90 minutes. Recently, it is the only produced in the market that offers robotic radiotherapy.

The increasing prevalence of the various types of cancer such as pancreas, liver, lung, prostate, spine, and cancer of throat boosts the growth of the market. According to the WHO, in 2018, cancer is the second leading cause of death globally as well as an estimated 9.6 million deaths due to cancer. On the other hand, according to the National Cancer Institute, in 2017, 15,270 children between 0 to 19 ages were diagnosed with cancer and 1,790 children were dead. Cyberknife radiotherapy system ensures targeted delivery of the radiotherapy to the cancerous cells as well as prevents the multiplication of the cells. It provides accurate as well as precise treatment. Hence, these factors enhance the growth of the market. On the other hand, growing non-invasive and minimally-invasive procedures as well as the adoption of the cyberknife in the developed countries propel the growth of the market. Besides, the manufacturer is involved in the development of the product with the advance technologies are bring the cyberknife in the great demand in the market. The government is also taking initiative towards funding in the research activities to launch a new product. Thereby, these increasing initiatives by the government drive the growth of the market. The increasing geriatric population also boosts the growth of the market. However, lack of awareness about the cyberknife yet remains one of the major restraints to this market. Besides, for operating the cyberknife for the treatment of the various types of cancer such as liver, lung, prostate, spine, cancer of the throat, pancreas requires skilled professionals. The skill professionals in developing countries are less. Therefore, the lack of skilled professionals is another factor that hinders the growth of the market. 

Based on the region, North America holds the highest market share of the cyberknife radiation therapy for lung cancer treatment market due to the rising incidences of lung cancer. In addition, the occurrence of highly advanced medical treatments in the region also boosts the growth of this market. Europe holds the second largest market share in this market due to the growing number of cases of cancer as well as increasing demand for the cyberknife radiotherapy technique. On the other hand, Asia Pacific is expected to grow at the highest CAGR in the forecast period as the healthcare infrastructure is developing at a fast pace especially in countries such as India.

Segment Covered

The report on global cyberknife market covers segments such as application, and end user. On the basis of application, the sub-markets include lung cancers, brain cancer, liver cancer, pancreas cancer, and other applications. On the basis of end user, the sub-markets include hospitals, clinics, ambulatory surgical center, radiotherapy centers, and other end users.

Companies Profiled:

The report provides profiles of the companies in the market such as GE Healthcare, Accuray Incorporated, Elekta AB, Nucletron B.V., Hitachi America, IBA Group, Mitsubishi Electric, Nordion Inc., Philips Healthcare, Varian Medical Systems, and Sumitomo Heavy Industries.

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the cyberknife market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.